Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 140 clinical trials
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

sirolimus -eluting stent with abluminal grooves containing a biodegradable polymer in High Bleeding Risk patients with coronary artery disease.

percutaneous coronary intervention
coronary artery disease
clopidogrel
antiplatelet therapy
stroke
  • 1 views
  • 26 Jan, 2021
  • 1 location
HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

The study aims to evaluate the safety and efficacy of biodegradable polymer sirolimus-eluting coronary stent system (HELIOS) in patients with coronary artery disease . The primary endpoint is

myocardial infarction
infarct
biodegradable polymer
revascularisation
arterial disease
  • 2 views
  • 22 Jan, 2021
  • 1 location
ABILITY Diabetes Global

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safety of Abluminus DES+ sirolimus- eluting stents (SES

coronary angioplasty
everolimus
fasting
coronary artery stenosis
plasma glucose
  • 0 views
  • 25 Jan, 2021
  • 86 locations
Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Anti-Platelet Therapy (DAPT) in patients undergoing percutaneous coronary intervention implanted sirolimus target- eluting stent with abluminal grooves containing a biodegradable polymer (Firehawk

dapt
ejection fraction
aspirin
biodegradable polymer
ischemia
  • 25 views
  • 25 Jan, 2021
  • 1 location
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

comparison between sirolimus-eluting Orsiro stent with biodegradable polymer and polymer-free stent platform with the same antiproliferative agent, Coroflex ISAR stent system. At the same time, clopidogrel

myocardial infarction
stenosis
coronary artery stenosis
stenotic
cardiac death
  • 0 views
  • 21 Jan, 2021
  • 7 locations
Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

SORT OUT XI Comparison of Combo stent and BioMatrix Alpha stent in the treatment of unselected patients with ischemic heart disease.

heart disease
sirolimus
  • 0 views
  • 24 Jan, 2021
  • 2 locations
Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World

The zotarolimus-eluting Endeavor Resolute stent is not inferior to the everolimus- eluting Xience V stent platform regarding a composite of cardiac death, myocardial infarction or target lesion revascularisation in a real-world population.

myocardial infarction
everolimus
infarct
zotarolimus
revascularisation
  • 7 views
  • 07 Nov, 2020
  • 1 location
Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease

To test whether immediate complete revascularization is non-inferior to staged (but within six weeks after index procedure) complete revascularization in Patients presenting with ACS, including Non-ST-elevation ACS (NSTEACS) and ST-elevation myocardial infarction (STEMI), with multivessel disease accepted for PCI

myocardial infarction
percutaneous coronary intervention
angiography
creatine kinase mb
unstable angina
  • 0 views
  • 25 Jan, 2021
  • 1 location
Sirolimus Plus Propranolol Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

estimated at 0.071 per 100,000 children. KHE presents with intermediate-malignant and locally aggressive characteristics but without distant metastases. This pilot trial studies sirolimus versus

prednisolone
metastases
neutrophil count
vascular tumors
hemangioendotheliomas
  • 48 views
  • 26 Jan, 2021
  • 1 location
Intravitreal Sirolimus as Therapeutic Approach to Uveitis

The purpose of this study is to find out about the safety and effectiveness of two different doses the study drug, sirolimus, administered intravitreally in patients with uveitis. The potential

corticosteroids
panuveitis
immunosuppressive agents
prednisone
  • 162 views
  • 24 Jan, 2021
  • 1 location